Cardlytics (CDLX) Tops Q2 EPS by 31c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.15), $0.31 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $69.64 million versus the consensus estimate of $75.39 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• SpaceX (SPCX) Indicated to Open at $174
• Down Detector and X Users Highlight Fidelity Investments System Crash
• Oxford Industries (OXM) PT Lowered to $40 at UBS Amid Top-line Weakness